Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) major shareholder Hudson Executive Capital Lp purchased 2,899,391 shares of the firm’s stock in a transaction on Tuesday, March 12th. The shares were acquired at an average price of $1.38 per share, with a total value of $4,001,159.58. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Shares of Corindus Vascular Robotics stock opened at $1.98 on Friday. Corindus Vascular Robotics Inc has a 1-year low of $0.70 and a 1-year high of $2.01.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its quarterly earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.04). The business had revenue of $4.67 million for the quarter, compared to analyst estimates of $5.60 million.

Institutional investors have recently modified their holdings of the business. Jane Street Group LLC bought a new position in shares of Corindus Vascular Robotics during the 4th quarter worth about $36,000. HRT Financial LLC bought a new position in Corindus Vascular Robotics in the 4th quarter valued at about $44,000. Virtu Financial LLC bought a new position in Corindus Vascular Robotics in the 4th quarter valued at about $64,000. Citadel Advisors LLC lifted its position in Corindus Vascular Robotics by 205.4% in the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock valued at $164,000 after acquiring an additional 77,829 shares in the last quarter. Finally, Barclays PLC bought a new position in Corindus Vascular Robotics in the 4th quarter valued at about $325,000.

TRADEMARK VIOLATION NOTICE: This report was first reported by Watch List News and is owned by of Watch List News. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.watchlistnews.com/corindus-vascular-robotics-inc-cvrs-major-shareholder-acquires-4001159-58-in-stock/2896309.html.

Corindus Vascular Robotics Company Profile

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Recommended Story: What is dollar cost averaging (DCA)?

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.